CA Stock MarketDetailed Quotes
MRVL Marvel Biosciences Corp
- 0.130
- +0.005+4.00%
15min DelayTrading Nov 7 14:06 ET
5.82MMarket Cap-2166P/E (TTM)
0.150High0.130Low96.50KVolume0.130Open0.125Pre Close12.91KTurnover0.19052wk High0.26%Turnover Ratio44.79MShares0.05552wk Low-0.06EPS TTM4.86MFloat Cap0.390Historical HighLossP/E (Static)37.42MShs Float0.010Historical Low-0.06EPS LYR16.00%Amplitude--Dividend TTM-2.10P/B1Lot Size--Div YieldTTM
Marvel Biosciences Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -88.19%30.04K | 658.48%43.51K | 2,283.87%211.66K | -35.55%887.52K | 96.24%618.54K | 24.36%254.36K | -99.25%5.74K | -96.32%8.88K | 124.62%1.38M | 177.32%315.19K |
| Gross profit | 88.19%-30.04K | -658.48%-43.51K | -2,283.87%-211.66K | 35.55%-887.52K | -96.24%-618.54K | -24.36%-254.36K | 99.25%-5.74K | 96.32%-8.88K | -124.62%-1.38M | -177.32%-315.19K |
| Operating expense | -52.56%207.7K | -3.69%208.49K | -18.48%228.08K | 16.19%1.36M | 56.60%417.4K | 135.62%437.85K | -28.15%216.47K | 4.13%279.77K | 141.45%1.17M | 46.82%266.55K |
| Selling and administrative expenses | -50.50%196.09K | -44.08%180.39K | -14.58%222.68K | 25.97%1.41M | 61.90%429.31K | 149.06%396.14K | 15.44%322.61K | -1.94%260.7K | 76.30%1.12M | 46.87%265.18K |
| -Selling and marketing expense | -65.99%56.82K | ---- | ---- | --312.46K | --145.38K | --167.08K | ---- | ---- | --0 | --0 |
| -General and administrative expense | -39.20%139.27K | -44.08%180.39K | -14.58%222.68K | -1.97%1.1M | 7.07%283.93K | 44.02%229.06K | 15.44%322.61K | -1.94%260.7K | 76.30%1.12M | 46.87%265.18K |
| Depreciation amortization depletion | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -17.84%152 | --0 |
| -Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -17.84%152 | --0 |
| Other operating expenses | -72.17%11.61K | 126.47%28.09K | -71.73%5.39K | -191.30%-48.09K | -966.38%-11.9K | 55.76%41.72K | -588.38%-106.14K | 586.57%19.07K | 135.24%52.67K | 44.63%1.37K |
| Operating profit | 65.65%-237.74K | -13.41%-252K | -52.34%-439.74K | 11.78%-2.25M | -78.08%-1.04M | -77.32%-692.22K | 79.16%-222.21K | 43.40%-288.65K | -132.05%-2.55M | -97.06%-581.74K |
| Net non-operating interest income (expenses) | -52.04%-35.06K | -126.95%-22.45K | -970.68%-20.71K | -2,380.44%-38.42K | -3,044.80%-12.71K | -7,016.98%-23.06K | -1,692.21%-9.89K | -618.96%-1.93K | 10.41%-1.55K | 39.16%-404 |
| Non-operating interest expense | 52.04%35.06K | 126.95%22.45K | 970.68%20.71K | --34.59K | --8.87K | --23.06K | --9.89K | --1.93K | --0 | --0 |
| Total other finance cost | ---- | ---- | ---- | 147.32%3.83K | ---- | ---- | ---- | ---- | -21.29%1.55K | -39.16%404 |
| Other net income (expenses) | -3,177.59%-34.51K | 4,783.80%41.64K | -929.38%-57.85K | -10.93%-4.78K | 961.07%2.78K | 33.35%-1.05K | 70.30%-889 | -5.62K | 99.78%-4.31K | 100.01%262 |
| Gain on sale of security | -3,177.59%-34.51K | 4,783.80%41.64K | -929.38%-57.85K | -10.93%-4.78K | 961.07%2.78K | 33.35%-1.05K | 70.30%-889 | ---5.62K | -162.70%-4.31K | -85.26%262 |
| Income before tax | 57.10%-307.31K | 0.08%-232.81K | -74.98%-518.3K | 10.29%-2.29M | -79.74%-1.05M | -82.61%-716.33K | 78.22%-232.99K | 41.94%-296.2K | 15.96%-2.55M | 72.12%-581.89K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 57.10%-307.31K | 0.08%-232.81K | -74.98%-518.3K | 10.29%-2.29M | -79.74%-1.05M | -82.61%-716.33K | 78.22%-232.99K | 41.94%-296.2K | 15.96%-2.55M | 72.12%-581.89K |
| Net income continuous operations | 57.10%-307.31K | 0.08%-232.81K | -74.98%-518.3K | 10.29%-2.29M | -79.74%-1.05M | -82.61%-716.33K | 78.22%-232.99K | 41.94%-296.2K | 15.96%-2.55M | 72.12%-581.89K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 57.10%-307.31K | 0.08%-232.81K | -74.98%-518.3K | 10.29%-2.29M | -79.74%-1.05M | -82.61%-716.33K | 78.22%-232.99K | 41.94%-296.2K | 15.96%-2.55M | 72.12%-581.89K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 57.10%-307.31K | 0.08%-232.81K | -74.98%-518.3K | 10.29%-2.29M | -79.74%-1.05M | -82.61%-716.33K | 78.22%-232.99K | 41.94%-296.2K | 15.96%-2.55M | 72.12%-581.89K |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 25.00%-0.06 | -50.00%-0.03 | 0.00%-0.01 | 66.67%-0.01 | 50.00%-0.01 | 52.94%-0.08 | 68.78%-0.02 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 25.00%-0.06 | -50.00%-0.03 | 0.00%-0.01 | 66.67%-0.01 | 50.00%-0.01 | 52.94%-0.08 | 68.78%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data